http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-230479-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a36328274867f46f8fc1fb9c868703
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
filingDate 2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf3c3aec642f21a6f14716d79005786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f035e544296376009163d2180240ad0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b894496040f059adc1bdca6b2cd8de5
publicationDate 2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-230479-B1
titleOfInvention Method for preparing 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one (Ziprasidone)
abstract The present invention provides a novel, industrially easily realisable and economically preferable process for production of pure 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one i.e., ziprasidone hydrochloride shown in the reaction scheme (II), (III), (IV), (V) and (VI). According to the invention the intermediate compound 5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one of Formula (III) is produced from 5-(2-bromoacethyl)-6-chloro-1,3-dihydro-2H-indole-2-one of Formula (IV). The highly pure ziprasidone base of Formula (II) is obtained in the reaction of 3-piperazinyl-1,2-benzisothiazol of Formula (VI) with 5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one of Formula (III) in an organic solvent or organic solvent mixture.
priorityDate 2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105131
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID452646
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10588416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414869995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2772144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415760527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420165368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507324
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID452646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424722900
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410634481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828

Total number of triples: 37.